[Not published yet] Single-dose HPV vaccine highly effective, researchers say – “Results of randomized controlled trial in Kenya bring new energy to eliminate cervical cancer worldwide”.21 Nov, 2021 | 22:56h | UTC
Single-dose HPV vaccine highly effective, researchers say – University of Washington School of Medicine
A national HPV vaccination program in England was associated with an estimated reduction in cervical cancer rates of 87% for those offered the vaccine at age 12–13 years.
Three-year follow-up of 2-dose versus 3-dose HPV vaccine
Nationwide cohort study in Sweden shows HPV vaccination linked to reduced risk of invasive cervical cancer
CDC: 92% of Human Papillomavirus–Attributable Cancers can be Targeted by HPV Vaccination
Meta-Analysis: Population-level Impact of HPV Vaccination Programs